202 related articles for article (PubMed ID: 37790943)
1. Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes.
Lippold S; Mistry K; Lenka S; Whang K; Liu P; Pitschi S; Kuhne F; Reusch D; Cadang L; Knaupp A; Izadi S; Dunkle A; Yang F; Schlothauer T
Front Immunol; 2023; 14():1260446. PubMed ID: 37790943
[TBL] [Abstract][Full Text] [Related]
2. Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometry.
Lippold S; Knaupp A; de Ru AH; Tjokrodirijo RTN; van Veelen PA; van Puijenbroek E; de Taeye SW; Reusch D; Vidarsson G; Wuhrer M; Schlothauer T; Falck D
MAbs; 2021; 13(1):1982847. PubMed ID: 34674601
[TBL] [Abstract][Full Text] [Related]
3. Differential influence on antibody dependent cellular phagocytosis by different glycoforms on therapeutic Monoclonal antibodies.
Kuhns S; Shu J; Xiang C; Guzman R; Zhang Q; Bretzlaff W; Miscalichi N; Kalenian K; Joubert M
J Biotechnol; 2020 Jun; 317():5-15. PubMed ID: 32361021
[TBL] [Abstract][Full Text] [Related]
4. A robust nanoscale RP HPLC-MS approach for sensitive Fc proteoform profiling of IgG allotypes.
Blöchl C; Gstöttner C; Sénard T; Stork EM; Scherer HU; Toes REM; Wuhrer M; Domínguez-Vega E
Anal Chim Acta; 2023 Oct; 1279():341795. PubMed ID: 37827688
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131).
Cymer F; Thomann M; Wegele H; Avenal C; Schlothauer T; Gygax D; Beck H
Biologicals; 2017 Nov; 50():125-128. PubMed ID: 28988621
[TBL] [Abstract][Full Text] [Related]
6. Affinity capillary electrophoresis - mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner.
Gstöttner C; Knaupp A; Vidarsson G; Reusch D; Schlothauer T; Wuhrer M; Domínguez-Vega E
Front Immunol; 2022; 13():980291. PubMed ID: 36159782
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
[TBL] [Abstract][Full Text] [Related]
8. Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients.
Thibault G; Paintaud G; Sung HC; Lajoie L; Louis E; The Getaid ; Desvignes C; Watier H; Gouilleux-Gruart V; Ternant D
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205175
[TBL] [Abstract][Full Text] [Related]
9. Benchmarking glycoform-resolved affinity separation - mass spectrometry assays for studying FcγRIIIa binding.
Gstöttner C; Lippold S; Hook M; Yang F; Haberger M; Wuhrer M; Falck D; Schlothauer T; Domínguez-Vega E
Front Immunol; 2024; 15():1347871. PubMed ID: 38469305
[TBL] [Abstract][Full Text] [Related]
10. Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131).
Mimoto F; Katada H; Kadono S; Igawa T; Kuramochi T; Muraoka M; Wada Y; Haraya K; Miyazaki T; Hattori K
Protein Eng Des Sel; 2013 Oct; 26(10):589-98. PubMed ID: 23744091
[TBL] [Abstract][Full Text] [Related]
11. CD3 Target Affinity Chromatography Mass Spectrometry as a New Tool for Function-Structure Characterization of T-Cell Engaging Bispecific Antibody Proteoforms and Product-Related Variants.
Lippold S; Hook M; Spick C; Knaupp A; Whang K; Ruperti F; Cadang L; Andersen N; Vogt A; Grote M; Reusch D; Haberger M; Yang F; Schlothauer T
Anal Chem; 2023 Jan; 95(4):2260-2268. PubMed ID: 36638115
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding.
Lu X; Machiesky LA; De Mel N; Du Q; Xu W; Washabaugh M; Jiang XR; Wang J
Sci Rep; 2020 Jan; 10(1):383. PubMed ID: 31941950
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.
Kratochvil S; McKay PF; Chung AW; Kent SJ; Gilmour J; Shattock RJ
Front Immunol; 2017; 8():1883. PubMed ID: 29326728
[TBL] [Abstract][Full Text] [Related]
14. Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies.
Tada M; Ishii-Watabe A; Suzuki T; Kawasaki N
PLoS One; 2014; 9(4):e95787. PubMed ID: 24752341
[TBL] [Abstract][Full Text] [Related]
15. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
Bredius RG; Fijen CA; De Haas M; Kuijper EJ; Weening RS; Van de Winkel JG; Out TA
Immunology; 1994 Dec; 83(4):624-30. PubMed ID: 7875742
[TBL] [Abstract][Full Text] [Related]
16. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
Front Immunol; 2020; 11():2049. PubMed ID: 32973813
[TBL] [Abstract][Full Text] [Related]
17. Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2.
Wines BD; Trist HM; Esparon S; Impey RE; Mackay GA; Andrews RK; Soares da Costa TP; Pietersz GA; Baker RI; Hogarth PM
Front Immunol; 2021; 12():666813. PubMed ID: 34759915
[TBL] [Abstract][Full Text] [Related]
18. Affinity Capillary Electrophoresis-Mass Spectrometry as a Tool to Unravel Proteoform-Specific Antibody-Receptor Interactions.
Gstöttner C; Hook M; Christopeit T; Knaupp A; Schlothauer T; Reusch D; Haberger M; Wuhrer M; Domínguez-Vega E
Anal Chem; 2021 Nov; 93(45):15133-15141. PubMed ID: 34739220
[TBL] [Abstract][Full Text] [Related]
19. Role of Fc gamma RIIa (CD32) in IgG anti-RhD-mediated red cell phagocytosis in vitro.
Wiener E; Dellow RA; Mawas F; Rodeck CH
Transfus Med; 1996 Sep; 6(3):235-41. PubMed ID: 8885153
[TBL] [Abstract][Full Text] [Related]
20. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
